Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
6
users have commented on this narrative
46
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
17
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Arvinas
AN
AnalystLowTarget
Consensus Narrative from 18 Analysts
Narrow Protein Degradation Focus Will Exacerbate Downturn Yet Spur Recovery
Key Takeaways Heavy reliance on a limited pipeline and milestone-driven partnerships exposes Arvinas to significant operational and revenue risks amid competitive and reimbursement pressures. Rising industry interest and regulatory tailwinds benefit Arvinas, but increased competition and pricing constraints threaten market share and long-term earnings growth.
View narrative
US$7.00
FV
1.3% overvalued
intrinsic discount
-49.68%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
Wave Life Sciences
AN
AnalystLowTarget
Consensus Narrative from 15 Analysts
Rising Cash Burn Will Hamper RNA Editing Yet Spark Hope
Key Takeaways Heavy reliance on unproven clinical outcomes and partnership milestone payments exposes the company to liquidity risk and continued net losses if delays or setbacks occur. Intensifying competition, clinical trial risks, and tightening pricing pressures threaten revenue growth, margin improvement, and Wave's ability to sustainably scale in the RNA therapeutics market.
View narrative
US$9.00
FV
8.4% overvalued
intrinsic discount
-25.08%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
Tandem Diabetes Care
AN
AnalystLowTarget
Consensus Narrative from 20 Analysts
Persistent Pricing Pressure And Commoditization Will Undermine Diabetes Care Outlook
Key Takeaways Intensifying pricing pressure, commoditization, and disruptive technologies threaten profitability, market share, and revenue growth, amplifying risks of technological obsolescence and margin compression. International expansion is challenged by regulatory and operational risks, while shifts toward value-based care reduce long-term market opportunities and earnings potential.
View narrative
US$10.00
FV
8.2% overvalued
intrinsic discount
5.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
Atlanta Braves Holdings
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Declining Cable Trends And MLB Audience Shrinkage Will Impair Returns
Key Takeaways Declining cable subscriptions and shifting demographics risk future revenue, eroding pricing power and audience size for broadcasting, attendance, and merchandising. Heavy real estate spending, rising player costs, and dependence on team performance increase financial risk and threaten long-term profitability.
View narrative
US$45.00
FV
2.4% undervalued
intrinsic discount
-1.36%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
Awfis Space Solutions
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Tier Expansion Will Depress Occupancy But Later Reveal Resilience
Key Takeaways Slower-than-expected adoption in new markets and increased competition from remote work trends may pressure occupancy rates, revenue growth, and seat pricing over time. High operational leverage from fixed costs and reliance on short-term leases expose Awfis to margin risk and earnings volatility, especially if demand softens.
View narrative
₹750.00
FV
25.2% undervalued
intrinsic discount
17.38%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
Ultimate Products
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Cost Pressures Will Strain Margins While Europe Will Offer Respite
Key Takeaways Ongoing cost pressures, supply chain risks, and rising competition threaten revenue growth and margin recovery despite international expansion and operational efficiency efforts. Innovation and ESG leadership are crucial, as private label growth and shifting consumer expectations could erode market share and challenge Ultimate Products' long-term resilience.
View narrative
UK£0.80
FV
25.0% undervalued
intrinsic discount
-2.91%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
LTFO
LT Foods
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Rising Environmental Costs And Basmati Volatility Will Erode Margins
Key Takeaways Over-reliance on basmati rice and shifting consumer preferences threaten future revenue growth and market resilience. Environmental challenges, regulatory pressures, and inventory risks could significantly erode profitability and strain long-term cash flows.
View narrative
₹393.00
FV
13.4% overvalued
intrinsic discount
10.70%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
Santos Brasil Participações
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts
Rising Environmental Regulations And Cost Pressures Will Stifle Expansion
Key Takeaways Rising environmental regulations, shifting shipping trends, and slow expansion approvals threaten margins, growth, and market position amid increasing competition. Heavy investment needs, mounting debt, and overcapacity risks could compress margins, strain cash flows, and restrict strategic or shareholder payouts.
View narrative
R$13.00
FV
8.5% overvalued
intrinsic discount
7.99%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
Nuvama Wealth Management
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Fee Compression, Fintech Rivalry Will Squeeze Margins And Spark Adaptation
Key Takeaways Rising fintech adoption and changing investor preferences threaten Nuvama's high-fee, advisory-led business model, risking margin compression and revenue volatility. Operational leverage and long-term growth depend on tech innovation and efficiency gains that must outpace escalating compliance and industry disruption risks.
View narrative
₹7.30k
FV
4.7% undervalued
intrinsic discount
8.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
Value any company in seconds
Popular companies